Literature DB >> 2403291

Bioavailability of iron and cyanide from oral potassium ferric hexacyanoferrate(II) in humans.

P Nielsen1, B Dresow, R Fischer, H C Heinrich.   

Abstract

After oral administration of 500 mg KFe[Fe(CN)6] labelled with 59Fe either in the ferric or ferrous position and with 14C in the cyanide group only 0.22% of the FeII and less than 0.04% of the FeIII were absorbed in three male volunteers. Only 2 mg non-complex bound 14C-labelled cyanide (0.03 mg CN-/kg body wt) were absorbed from 500 mg [14C]KFeHCF, which is about a factor of 20-100 below the lethal dose in humans (0.5-3.5 mg CN-/kg body wt). Therefore, iron(III) hexacyanoferrates(II) can be considered as safe antidotes, i.e. for inhibiting the intestinal absorption of radiocaesium or for accelerating the excretion of already absorbed 134/137Cs in the case of a severe nuclear accident.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2403291     DOI: 10.1007/bf01973468

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  15 in total

Review 1.  Toxicological and clinical aspects of cyanide metabolism.

Authors:  R G Baumeister; H Schievelbein; G Zickgraf-Rüdel
Journal:  Arzneimittelforschung       Date:  1975-07

2.  RETENTION OF RADIOCAESIUM BY THE RAT AS INFLUENCED BY PRUSSIAN BLUE AND OTHER COMPOUNDS.

Authors:  V NIGROVIC
Journal:  Phys Med Biol       Date:  1965-01       Impact factor: 3.609

3.  Internal dose from carbon-14 labelled compounds. The metabolism of carbon-14 labelled potassium cyanide in the rat.

Authors:  F E Crawley; E A Goddard
Journal:  Health Phys       Date:  1977-03       Impact factor: 1.316

4.  Increased excretion of 137Cs in humans by Prussian Blue.

Authors:  K Madshus; A Strömme
Journal:  Z Naturforsch B       Date:  1968-03       Impact factor: 1.047

5.  [Hexacyanoferrates (II) as thallium antidotes. Preparation and properties].

Authors:  P Dvorák
Journal:  Arzneimittelforschung       Date:  1970-12

6.  Check of Prussian blue for antidotal efficacy in thallium intoxication.

Authors:  A G Rauws; A N van Heyst
Journal:  Arch Toxicol       Date:  1979-12       Impact factor: 5.153

7.  Application of metal ferrocyanide-anion exchange resin to the enhancement of elimination of 137Cs from human body.

Authors:  T A Iinuma; M Izawa; K Watari; Y Enomoto; N Matsusaka; J Inaba; T Kasuga; T Nagai
Journal:  Health Phys       Date:  1971-01       Impact factor: 1.316

8.  [Effects of cyanoferrates on the excretion of radiocesium in rats and goats].

Authors:  F Havlícek; I Kleisner; P Dvorák; J Pospísil
Journal:  Strahlentherapie       Date:  1967-09

9.  Urinary excretion of iron.

Authors:  J H Dagg; J A Smith; A Goldberg
Journal:  Clin Sci       Date:  1966-06       Impact factor: 6.124

10.  Prevention of enteral radiocesium absorption by hexacyanoferrates(II) in piglets.

Authors:  P Nielsen; R Fischer; H C Heinrich; A A Pfau
Journal:  Experientia       Date:  1988-06-15
View more
  1 in total

Review 1.  Is IQG-607 a Potential Metallodrug or Metallopro-Drug With a Defined Molecular Target in Mycobacterium tuberculosis?

Authors:  Bruno L Abbadi; Valnês da Silva Rodrigues-Junior; Adilio da Silva Dadda; Kenia Pissinate; Anne D Villela; Maria M Campos; Luiz G de França Lopes; Cristiano V Bizarro; Pablo Machado; Eduardo H S Sousa; Luiz A Basso
Journal:  Front Microbiol       Date:  2018-05-01       Impact factor: 5.640

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.